Ann. today "Biosignal anti-corrosive for oil & gas industry passes university tests"
Key finding "The study found that one Biosignal anti-biofilm agent at a low dose of 20 parts per million (ppm) is effective in preventing the growth of Desulfovibrio desulfuricans biofilm for up to 4 days under flow conditions that replicate those found inside pipelines."
I am unsure how to interpret this... Does this mean other biocides don't do this? Is this 4 days more than what would normally happen? Results were stated to be good though.
Looking good for commercial application in this field. Once the April results are available and if they're good, I imagine they won't waste any time in developing the product for full scale commercial sale. In previous update BOS has said it could spin out a company for tentative potential launch 2H08.
From the AR 06: "Microbial corrosion causes $100s of millions of dollars in infrastructure damage and production down-time every year in the Australian oil and gas industry alone." Then from a further ann "Microbiologically-Induced Corrosion (MIC) of steel infrastructure costs the Aust oil & gas industry $675m pa" Product is safer & works in low parts per million.
On the downside, the far larger medical device field looks like it may be an unsuccessful pursuit for BOS. "The level of anti-bacterial activity achieved so far using the attached compounds is not sufficient for commercial applications"
Maybe it's similar to problems experienced with the contact lenses. I imagine further R&D into attachment of the compound could fix this problem, but with the focus on it being scaled down.... we'll have to wait and see.
Japanese deals hopefully should filter through the pipeline soon. IMO even if the company gets just one application of this technology through to commercialization it would justify the current SP by a multiple.
Nothing set in stone but still happy to hold.
BOS Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
